Clene Inc
Veridion Score
Composite trend over time
Why is CLNN moving today?
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CLNN.
CLNN insider activity
Clene Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$7.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | 2026-05-12 | Ugwumba Chidozie | Insider | sell | $6.20 | 73,296 | 103,417 | $454K | SEC Form 4 |
| 2026-05-13 | 2026-05-11 | Ugwumba Chidozie | Insider | sell | $6.75 | 22,177 | 176,713 | $150K | SEC Form 4 |
| 2026-05-05 | 2026-05-04 | Ugwumba Chidozie | Insider | sell | $6.80 | 72,884 | 198,890 | $496K | SEC Form 4 |
| 2026-05-05 | 2026-05-01 | Ugwumba Chidozie | Insider | sell | $6.01 | 5,795 | 271,774 | $35K | SEC Form 4 |
| 2026-04-30 | 2026-04-30 | Ugwumba Chidozie | Insider | sell | $6.08 | 5,736 | 277,569 | $35K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 62 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCLNN contract awards, year to date.
Public federal awards linked to this ticker.
CLNN lobbying filings, year to date.
Registered lobbying filings matched to Clene Inc.
LOT SIXTEEN LLC
CAPITOL HILL CONSULTING GROUP
LOT SIXTEEN LLC